Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Typhim Vi vs Pneumovax 23 for SPAD Diagnosis
NCT02429531Phase 4Completed
- Sponsor
- UZ Leuven
- Start
- Oct 2015
- Primary completion
- Aug 2018
- Modality
- Split/Subunit Vaccines, Recombinant Protein Vaccines
- Countries
- 1
01
Overview
A Phase 4 trial of salmonella typhi capsular polysaccharide vaccine in Specific polysaccharide antibody deficiency (SAD), sponsored by UZ Leuven. Started Oct 2015; status: completed.
02
Drugs
salmonella typhi capsular polysaccharide vaccine
03
Conditions
Specific polysaccharide antibody deficiency (SAD)
Beyond the preview
Go deeper on NCT02429531.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02429531.